Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine

Clinical trial NCT01845337 · COMPLETED

Trial details

NCT number: NCT01845337
Sponsor: University of Edinburgh
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Cancer Cancer of Unknown Primary Site Pancreatic Cancer Bile Duct Neoplasms

Start date: 2014-02-05
Primary completion: 2020-03-18
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.